about
Network-based analysis of comorbidities risk during an infection: SARS and HIV case studiesDynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital dischargeSevere acute respiratory syndrome coronavirus as an agent of emerging and reemerging infectionKnowledge, attitudes and practices relating to influenza A(H7N9) risk among live poultry traders in Guangzhou City, ChinaThe role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis.A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan.Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors.Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor.Longer term follow up of aerobic capacity in children affected by severe acute respiratory syndrome (SARS).A correlation between the severity of lung lesions on radiographs and clinical findings in patients with severe acute respiratory syndrome.Coping with future epidemics: Tai chi practice as an overcoming strategy used by survivors of severe acute respiratory syndrome (SARS) in post-SARS Hong KongInitial viral load and the outcomes of SARS.Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity.Hypocortisolism in survivors of severe acute respiratory syndrome (SARS).Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.MERS-CoV papain-like protease (PLpro): expression, purification, and spectroscopic/thermodynamic characterization.Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome.Severe Acute Respiratory Syndrome
P2860
Q21284301-BAE906FC-8FCF-4435-A6BE-920FA7A6E504Q24805143-9B2CE1EB-A263-4A84-BFB4-650CA0FECBCCQ28383088-3371C4BA-B22C-4227-B0F2-01A4E432D62CQ28396606-28406224-BF8E-43EA-A733-75D4C25F29F6Q30234893-6EFF24D1-D0E2-41A4-AB91-FA82C9AAD8F3Q33537455-52FDD076-D8A5-4B6B-B8D3-B800175FBF64Q35536273-1942ADDE-1D18-4BEF-B581-BCA988548CCCQ35635252-C032E42D-78C1-46DE-9F34-06C040A063C1Q36148707-C73D597C-CC96-431F-87AF-02D93075CE14Q37063722-238BBA8E-E886-4C58-A219-B5FAB95E5B7FQ37321325-356B67D3-481B-42D0-8043-1D8DA8C84F76Q37610938-1383AF09-B5AE-4C66-A75D-FB6CCECFE4B5Q38839402-22F66057-D0D1-47EA-8CEF-72042C59B472Q40393123-723BFB0D-F039-42E3-9B5A-4C18D19329A1Q46629460-A37EB5AF-B98E-48E6-9FF7-29A8093DA29CQ50572228-99B1C6D5-CAC2-4002-A92E-8C4905AFF958Q51795571-C6BFC254-BCCE-43BC-AD5E-F1C5DFB7B24AQ55442944-0EF15ACC-4CD5-4B82-B958-E13EDDE02BC7Q59187114-9942B544-3D65-4817-A59B-9038C2702F67
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
SARS: prognosis, outcome and sequelae.
@ast
SARS: prognosis, outcome and sequelae.
@en
type
label
SARS: prognosis, outcome and sequelae.
@ast
SARS: prognosis, outcome and sequelae.
@en
prefLabel
SARS: prognosis, outcome and sequelae.
@ast
SARS: prognosis, outcome and sequelae.
@en
P2093
P2860
P1433
P1476
SARS: prognosis, outcome and sequelae
@en
P2093
P2860
P304
P356
10.1046/J.1440-1843.2003.00522.X
P478
P577
2003-11-01T00:00:00Z